{
  "id": 6297532,
  "title": "Moonwalk reloads with $70M and new RNAi prospects for obesity",
  "url": "https://urgent.news/2026/09/08/moonwalk-reloads-with-70m-and-new-rnai-prospects-for-obesity",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T15:52:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/moonwalk-series-b-obesity-rna-interference/829784/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}